ANTI-NEPHROLITHIASIS ACTIVITY OF ETHANOL EXTRACT OF IPOMOEA CARNEA JACQ. AGAINST ETHYLENE GLYCOL-INDUCED UROLITHIASIS IN RATS

MADAN L KAUSHIK; NISHANT GOUTAM; MAHENDRA SINGH ASHAWAT

doi:10.22159/ajpcr.2025v18i5.54311

Authors

MADAN L KAUSHIK Department of Pharmacology, Aadarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, Saharanpur, Uttar Pradesh, India.
NISHANT GOUTAM Department of Pharmacology, Aadarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, Saharanpur, Uttar Pradesh, India. https://orcid.org/0000-0002-2732-5230
MAHENDRA SINGH ASHAWAT Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, Kangra, Himachal Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i5.54311

Keywords:

Ipomoea carnea Jacq., Urolithiasis, Ethylene Glycol, Diuretic Properties, Phytochemicals

Abstract

Objective: Urolithiasis, one of the significant urological conditions, develops due to excessive calcium oxalate crystal accumulation, paving the way for various renal disorders. The use of conventional drug therapies often leads to numerous health consequences as far as their adverse effects are concerned, herbal interventions on the other hand have always been a ray of hope in that case. The present research investigated the therapeutic efficacy of ethanolic extract of Ipomoea carnea Jacq. (EEIC), in ethylene glycol (EG)-induced urolithiasis in rat animal models, diuretic potential, and antiurolithiatic activity were evaluated through the assessment of various biochemical and histopathological parameters.

Methods: Initially, key bioactive compounds were identified through phytochemical screening, qualitative analysis, and quantitative estimation of EEIC. Thirty, male Wistar albino rats were used in the study, divided into five groups, each group containing six animals. Group 1 (normal control), Group 2 (negative control: EG 0.75% v/v), Group 3 (positive control: Lumasiran 3 mg/kg), and Groups 4 and 5 (EEIC treated test groups: 250 mg/kg and 500 mg/kg., p.o., respectively). Different biochemical parameters were evaluated in urine, serum, and kidney homogenate after the 28th day. Pathological examinations of renal tissues were also performed.

Results: EEIC treatment demonstrated significant dose-dependent improvements in urinary and serum biomarkers linked to kidney stones and renal health. At doses of 250 and 500 mg/kg, urine volume significantly increased (2.17 mL, p<0.01; 2.35 mL, p<0.005), with enhanced Na+ and K+ excretion. After 28 days, urine output reached 4.31±0.38 mL (p<0.005), urine pH shifted from acidic (5.27±0.36) to alkaline (6.26±0.19, p<0.05), and levels of calcium, oxalate, and uric acid decreased significantly. EEIC also improved serum creatinine levels, renal tissue integrity, and supported magnesium and citrate increases, aligning with prior research.

Conclusion: The present study highlights that EEIC treatment improved serum creatinine levels, renal tissue integrity, and increased magnesium and citrate levels and has promising potential as a natural therapeutic alternative against urolithiasis, warranting further clinical investigation.

Downloads

Download data is not yet available.

References

Kachkoul R, Touimi GB, El Mouhri G, El Habbani R, Mohim M, Lahrichi A. Urolithiasis: History, epidemiology, aetiologic factors and management. Malays J Pathol. 2023;45(3):333-52. PMID: 38155376

Gadge NB, Jalalpure SS. Curative treatment with extracts of Bombax ceiba fruit reduces risk of calcium oxalate urolithiasis in rats. Pharm Biol. 2012;50(3):310-7. doi: 10.3109/13880209.2011.604332, PMID: 22321032

Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018;5(4):205-14. doi: 10.1016/j. ajur.2018.08.007, PMID: 30364478

Skolarikos A, Somani B, Neisius A, Jung H, Petřík A, Tailly T, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: An EAU guidelines update. Eur Urol. 2024;86(4):343-63. doi: 10.1016/j.eururo.2024.05.029, PMID: 39069389

Papadopoulos G, Bourdoumis A, Kachrilas S, Bach C, Buchholz N, Masood J. Hyoscine N-butylbromide (Buscopan®) in the treatment of acute ureteral colic: What is the evidence? Urol Int. 2014;92(3):253-7. doi: 10.1159/000358015, PMID: 24576895

Carter MR, Green BR. Kidney stones: Emergency department diagnosis and treatment. Am Fam Physician. 2019;99(8):490-6.

Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, et al. 2007 guideline for the management of ureteral calculi. J Urol. 2007 Dec;178(6):2418-34. doi: 10.1016/j.juro.2007.09.107, PMID: 17993340

Türk C, Neisius A, Petřík A, Seitz C, Skolarikos A, Somani B, et al. EAU Guidelines on Urolithiasis. Arnhem, The Netherlands: European Association of Urology; 2025.

Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed Res Int. 2014;2014:808302. doi: 10.1155/2014/808302, PMID: 24949473

Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris. Pharmacogn Rev. 2014 Jan-Jun;8(15):45-51. doi: 10.4103/0973-7847.125530, PMID: 24600195

Ahmad M, Butt MA, Zhang G, Sultana S, Tariq A, Zafar M. Bergenia ciliata: A comprehensive review of its traditional uses, phytochemistry, pharmacology and safety. Biomed Pharmacother. 2018;97:708-21. doi: 10.1016/j.biopha.2017.10.141, PMID: 29102914

Bency BT, Remya K, Rani S, Rasheed SP, Azeem AK. Rotula aquatica Lour.: A review on medicinal uses, phytochemistry, and pharmacological actions. Indian J Pharm Biol Res. 2017;5(4):4-9. doi: 10.30750/IJPBR.5.4.2

Kumari I, Kaurav H, Choudhary G. Rubia cordifolia (Manjishtha): A review based upon its Ayurvedic and medicinal uses. Himalayan J Health Sci. 2021;6(2):17-28. doi: 10.22270/HJHS.V6I2.96

Nazim NB, Khatun A, Mannan A. Traditional uses, phytochemistry and pharmacology of Ipomoea carnea: An updated systematic review. Int J Res Anal Rev. 2024;11(1):779-96.

Srivastava D, Shukla K. Pharmaceutical efficacy of Ipomoea carnea. Biol Forum Int J. 2015;7:225-35.

Khan MZ, Zahra SS, Ahmed M, Fatima H, Mirza B, Haq IU, et al. Polyphenolic profiling of Ipomoea carnea Jacq. by HPLC-DAD and its implications in oxidative stress and cancer. Nat Prod Res. 2019;33(14):2099-104. doi: 10.1080/14786419.2018.1482551, PMID: 29873254

Akshaya M, Swetha KS, Keerthana D, Vadivel V. In vitro studies on wound healing mechanisms of leaves of Ipomoea carnea, an Indian ethnomedicine. S Afr J Bot. 2023;154:239-50. doi: 10.1016/j. sajb.2023.01.031

Wadnerwar N, Deogade M. Comparative phytochemical assessment of “Ashodhita” and “Shodhita” seeds of Ipomoea carnea Jacq. (an ethnopharmacological drug). Biomed Res. 2021;32(4):85-91.

Ullah Khan S, Ullah F, Hussain M, Zahid Ihsan M, Mehmood S, Ali L, et al. Phytochemical analysis and phytotoxic evaluation of Chenopodium glaucum L. J King Saud Univ Sci. 2023 Apr;35(3):102571. doi: 10.1016/j.jksus.2023.102571

Masfria, Sumaiyah, Syahputra H, Silvia. Antibacterial and anti-inflammatory activities of nanosimplicia Phyllantus emblica L. fruit in suspension formulation. Int J Appl Pharm. 2025;17(2):376-83. doi: 10.22159/ijap.2025v17i2.52608

Pandey B, Rajbhandari M. Estimation of total phenolic and flavonoid contents in some medicinal plants and their antioxidant activities. Nepal J Sci Technol. 2015 Feb;15(1):53-60. doi: 10.3126/NJST.V15I1.12010

Siddiqui N, Rauf A, Latif A, Mahmood Z. Spectrophotometric determination of the total phenolic content, spectral and fluorescence study of the herbal Unani drug Gul-e-Zoofa (Nepeta bracteata Benth). J Taibah Univ Med Sci. 2017 Aug;12(4):360-3. doi: 10.1016/j. jtumed.2016.11.006, PMID: 31435264

Rosalina V, Hasibuan PA, Satria D, Meiyanto E, Putra DP, Chatri M, et al. Antioxidant activity of flavonoid rich fraction of (Vernonia amygdalina Delile.) leaves. Int J Appl Pharm. 2024;16(Special Issue 4):6-10. doi: 10.22159/ijap.2024v16s4.52249

Malik SK. Qualitative and quantitative estimation of terpenoid contents in some important plants of Punjab, Pakistan. Pak J Sci. 2023;69(2):150- 4. doi: 10.57041/PJS.V69I2.364

Hart SE. Diuretic and saluretic activity. In: Hock FJ, Maas J, Hock FJ, Mayer D, editors. Drug Discovery and Evaluation: Pharmacological Assays. 3rd ed. Berlin: Springer; 2015. p. 1-9. doi: 10.1007/978-3-642- 27728-3_17-1

Lipschitz WL, Hadidian Z, Kerpcsar A. Bioassay of diuretics. J Pharmacol Exp Ther. 1943;79(2):97-110. doi: 10.1016/S0022- 3565(25)09341-3

Khalid MS, Singh RK, Reddy IV, Kumar SJ, Kumar BS, Kumar GN, et al. Anti-inflammatory activity of aqueous extract of Ipomoea carnea Jacq. Pharmacologyonline. 2011;1:326-31.

Patel VB, Acharya N. Effect of Macrotyloma uniflorum in ethylene glycol induced urolithiasis in rats. Heliyon. 2020;6(6):e04253. doi: 10.1016/j.heliyon.2020.e04253, PMID: 32637686

Dinnimath BM, Jalalpure SS, Patil UK. Antiurolithiatic activity of natural constituents isolated from Aerva lanata. J Ayurveda Integr Med. 2017;8(4):226-32. doi: 10.1016/j.jaim.2016.11.006, PMID: 29169771

Karadi RV, Gadge NB, Alagawadi KR, Savadi RV. Effect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol. 2006;105(1-2):306-11. doi: 10.1016/j. jep.2005.11.004, PMID: 16386862

Atmani F, Slimani Y, Mimouni M, Hacht B. Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int. 2003;92(1):137-40. doi: 10.1046/j.1464- 410x.2003.04289.x, PMID: 12823398

Wang R, Younis EM, Priya Veeraraghavan VP, Tian C. Antiurolithiatic effect of fucoxanthin on ethylene glycol-induced renal calculus in experimental rats. J King Saud Univ Sci. 2020;32(3):1896-901. doi: 10.1016/j.jksus.2020.01.027

Hasnat H, Shompa SA, Islam MM, Alam S, Richi FT, Emon NU, et al. Flavonoids: A treasure house of prospective pharmacological potentials. Heliyon. 2024;10(6):e27533. doi: 10.1016/j.heliyon.2024. e27533, PMID: 38496846

Kumar S, Kumari D, Singh B. Genus Rauvolfia: A review of its ethnopharmacology, phytochemistry, quality control/quality assurance, pharmacological activities and clinical evidence. J Ethnopharmacol. 2022;295:115327. doi: 10.1016/j.jep.2022.115327, PMID: 35504505

Mobasheri L, Ahadi M, Beheshti Namdar A, Alavi MS, Bemidinezhad A, Moshirian Farahi SM, et al. Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals. Biomed Pharmacother. 2023;167:115502. doi: 10.1016/j.biopha.2023.115502, PMID: 37734266

Ge J, Liu Z, Zhong Z, Wang L, Zhuo X, Li J, et al. Natural terpenoids with anti-inflammatory activities: Potential leads for anti-inflammatory drug discovery. Bioorg Chem. 2022;124:105817. doi: 10.1016/j. bioorg.2022.105817, PMID: 35490583

Gorabi AM, Aslani S, Imani D, Razi B, Sathyapalan T, Sahebkar A. Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials. Phytother Res. 2021;35(12):6754-67. doi: 10.1002/PTR.7262, PMID: 34472150

Allam EA, Sabra MS. Plant-based therapies for urolithiasis: A systematic review of clinical and preclinical studies. Int Urol Nephrol. 2024;56(12):3687-718. doi: 10.1007/s11255-024-04148-9, PMID: 39042342

Pareta SK, Patra KC, Mazumder PM, Sasmal D. Establishing the principle of herbal therapy for antiurolithiatic activity: A review. J Pharmacol Toxicol. 2011;6(3):321-32. doi: 10.3923/jpt.2011.321.332

Ngamlai EV, Pradhan RB, Lalbiaknii PC, Ralte V, Lalnunmawia F, Vanlalhluna PC, et al. Diuretic activity evaluation and chemical composition analysis of Hedyotis scandens extract from Mizoram, India, in rat models. J Ethnopharmacol. 2024;319(1):117079. doi: 10.1016/j.jep.2023.117079, PMID: 37659758

Li C, Wen R, Liu W, Liu Q, Yan LP, Wu JX, et al. Diuretic effect and metabolomics analysis of crude and salt-processed Plantaginis Semen. Front Pharmacol. 2020;11:563157. doi: 10.3389/fphar.2020.563157, PMID: 33390941

Durant-Archibold AA, Santana AI, Gupta MP. Ethnomedical uses and pharmacological activities of most prevalent species of genus Piper in Panama: A review. J Ethnopharmacol. 2018;217:63-82. doi: 10.1016/j. jep.2018.02.008, PMID: 29428241

Puri V, Nagpal M, Singh I, Singh M, Dhingra GA, Huanbutta K, et al. A comprehensive review on nutraceuticals: Therapy support and formulation challenges. Nutrients. 2022;14(21):4637. doi: 10.3390/ nu14214637, PMID: 36364899

Gaybullaev A, Kariev S. Phytotherapy of calcium urolithiasis with extracts of medicinal plants: Changes of diuresis, urine pH and crystalluria. Med Health Sci J. 2012;10(1):74-80. doi: 10.15208/ mhsj.2012.14

Bhaskar R, Rani R, Singh AP, Singh AP. Herbal drug use to treat urolithiasis: An updated review. J Drug Deliv Ther. 2024;14(11):146-9. doi: 10.22270/JDDT.V14I11.6866

Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23(Suppl 16):S165-9. doi: 10.5167/UZH-45805, PMID: 21170875

Kant R, Singh TG, Singh S. Mechanistic approach to herbal formulations used for urolithiasis treatment. Obes Med. 2020;19:100266. doi: 10.1016/j.obmed.2020.100266

Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: Alternative or complementary? Planta Med. 2009;75(10):1095-103. doi: 10.1055/s-0029-1185719, PMID: 19444769

Gang X, Liu F, Mao J. Lumasiran for primary hyperoxaluria type 1: What we have learned? Front Pediatr. 2023;10:1052625. doi: 10.3389/ fped.2022.1052625

Kaleeswaran B, Ramadevi S, Murugesan R, Srigopalram S, Suman T, Balasubramanian T. Evaluation of anti-urolithiatic potential of ethyl acetate extract of Pedalium murex L. on struvite crystal (kidney stone). J Tradit Complement Med. 2019;9(1):24-37. doi: 10.1016/j. jtcme.2017.08.003, PMID: 30671363

Jagannath N, Chikkannasetty SS, Govindadas D, Devasankaraiah G. Study of antiurolithiatic activity of Asparagus racemosus on albino rats. Indian J Pharmacol. 2012 Oct;44(5):576-9. doi: 10.4103/0253- 7613.100378, PMID: 23112416

Kuo CY, Kao ES, Chan KC, Lee HJ, Huang TF, Wang CJ. Hibiscus sabdariffa L. extracts reduce serum uric acid levels in oxonate-induced rats. J Funct Foods. 2012 Jan;4(1):375-81. doi: 10.1016/J. JFF.2012.01.007

Vyas BA, Vyas RB, Joshi SV, Santani DD. Antiurolithiatic activity of whole-plant hydroalcoholic extract of Pergularia daemia in rats. J Young Pharm. 2011;3(1):36-40. doi: 10.4103/0975-1483.76417, PMID: 21607052

Putri IS, Siwi GN, Budiani DR, Rezkita BE. Protective effect of Moringa seed extract on kidney damage in rats fed a high-fat and high-fructose diet. J Taibah Univ Med Sci. 2023;18(6):1545-52. doi: 10.1016/j.jtumed.2023.07.001, PMID: 37701847

Ghareeb MA, Mohammed HS, Aboushousha T, Lotfy DM, El- Shazly MA, Sobeh M, et al. Ipomoea carnea mitigates ethanol-induced ulcers in irradiated rats via Nrf2/HO-1 pathway: An in vivo and in silico study. Sci Rep. 2024;14(1):3469. doi: 10.1038/s41598-024-53336-1, PMID: 38342928

Fatima N, Rahman MM, Khan MA, Fu J. A review on Ipomoea carnea: Pharmacology, toxicology and phytochemistry. J Complement Integr Med. 2014;11(2):55-62. doi: 10.1515/JCIM-2013-0046, PMID: 24651023

Mehallah H, Djebli N, Ngoc Khanh P, Xuan Ha N, Thi Ha V, Thu Huong T, et al. In silico and in vivo study of anti-inflammatory activity of Morinda longissima (Rubiaceae) extract and phytochemicals for treatment of inflammation-mediated diseases. J Ethnopharmacol. 2024;328:118051. doi: 10.1016/j.jep.2024.118051, PMID: 38493905

Mattosinhos PD, Sarandy MM, Novaes RD, Esposito D, Gonçalves RV. Anti-inflammatory, antioxidant, and skin regenerative potential of secondary metabolites from plants of the Brassicaceae family: A systematic review of in vitro and in vivo preclinical evidence (biological activities Brassicaceae skin diseases). Antioxidants (Basel). 2022;11(7):1346. doi: 10.3390/antiox11071346, PMID: 35883837

Gupta H. Exploring the antiurolithiatic and diuretic potential of nausadar and plant extracts in ethylene glycol-induced urolithiasis in Wistar rats. Afr J Biomed Res. 2024;27(3):3464-72. doi: 10.53555/ AJBR.v27i3S.2972

Hong SY, Qin BL. The protective role of dietary polyphenols in urolithiasis: Insights into antioxidant effects and mechanisms of action. Nutrients. 2023;15(17):3753. doi: 10.3390/nu15173753, PMID: 37686790

Dalbeth N, Haskard DO. Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol. 2005;17(3):314-8. doi: 10.1097/01.BOR.0000157041.12116.69, PMID: 15838243